Hepatitis Web Study

References

  1. Hepatitis B Virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1-25. Available at:
    [The following link will open in a new window. Centers for Disease Control and Prevention - Accessed September 2, 2008]
  2. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR. 2005;54(RR-16):1-31. Available at:
    [The following link will open in a new window. Centers for Disease Control and Prevention - Accessed December 16, 2008]
  3. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR. 2006;55(RR-16):1-25. Available at:
    [The following link will open in a new window. Centers for Disease Control and Prevention - Accessed December 16, 2008
  4. Xu ZY, Liu CB, Francis DP, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 1985;76:713-8.
    [The following link will open in a new window. PubMed Abstract]
  5. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA. 1987;257:2612-6.
    [The following link will open in a new window. PubMed Abstract]
  6. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2:1099-102.
    [The following link will open in a new window. PubMed Abstract]
  7. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002;67:20-6.
    [The following link will open in a new window. PubMed Abstract]
  8. Xu DZ, Yan YP, Zou S, et al. Role of placental tissues in the intrauterine transmission of hepatitis B virus. Am J Obstet Gynecol. 2001;185:981-7
    [The following link will open in a new window. PubMed Abstract]
  9. Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol. 2001;184:1514-8.
    [The following link will open in a new window. PubMed Abstract]
  10. Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol. 2004;10:437-8.
    [The following link will open in a new window. PubMed Abstract]
  11. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang ZL, Ng HT. Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet. 1988;2:833-4.
    [The following link will open in a new window. PubMed Abstract]
  12. Ghaffar YA, elSobky MK, Raouf AA, Dorgham LS.Mother-to-child transmission of hepatitis B virus in a semirural population in Egypt. J Trop Med Hyg. 1989;92:20-6.
    [The following link will open in a new window. PubMed Abstract]
  13. Beasley RP, Stevens CE, Shiao IS, Meng HC. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet. 1975;2:740-1.
    [The following link will open in a new window. PubMed Abstract]
  14. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol. 2004;10:3215-7.
    [The following link will open in a new window. PubMed Abstract]
  15. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2003;10:294-7.
    [The following link will open in a new window. PubMed Abstract]
  16. Li XM, Yang YB, Hou HY, et al. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol. 2003;9:1501-3
    [The following link will open in a new window. PubMed Abstract]
  17. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet. 2002;359:1488-9.
    [The following link will open in a new window. PubMed Abstract]
  18. Zhu Q, Yu G, Yu H, Lu Q, Gu X, Dong Z, Zhang X. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J (Engl). 2003;116:685-7.
    [The following link will open in a new window. PubMed Abstract]
  19. Davies G, Wilson RD, Desilets V, et al. Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus. J Obstet Gynaecol Can. 2003;25:145-48, 149-52.
    [The following link will open in a new window. PubMed Abstract]
  20. Alexander JM, Ramus R, Jackson G, Sercely B, Wendel GD Jr. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol. 1999;7:283-6.
    [The following link will open in a new window. PubMed Abstract]
  21. Saari TN; American Academy of Pediatrics Committee on Infectious Diseases. Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 2003;112:193-8.
    [The following link will open in a new window. PubMed Abstract]
  22. Lo KJ, Lee SD, Tsai YT, Wu TC, Chan CY, Chen GH, Yeh CL. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology 1988;8:1647-50.
    [The following link will open in a new window. PubMed Abstract]
  23. McMahon BJ, Bruden DL, Petersen KM, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005;142:333-41.
    [The following link will open in a new window. PubMed Abstract]
  24. Boxall EH, Sira J, Standish RA, et al. Natural history of hepatitis B in perinatally infected carriers. Arch Dis Child Fetal Neonatal Ed. 2004;89:F456-60.
    [The following link will open in a new window. PubMed Abstract]
  25. Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology. 1990;99:805-10.
    [The following link will open in a new window. PubMed Abstract]
  26. Beasley RP, Hwang L-Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983;147:185-90.
    [The following link will open in a new window. PubMed Abstract]

[Back to Question | Back to Discussion]

CME Credit | CNE Credit | Back to Top